MM466Homo sapiens (Human)Cancer cell line

Also known as: MM 466

🤖 AI SummaryBased on 3 publications

Quick Overview

MM466 is a melanoma cell line with BRAF mutation.

Detailed Summary

MM466 is a melanoma cell line that has been extensively studied for its BRAF mutation status. Research indicates that MM466 carries the V599E mutation in the BRAF gene, which is a common mutation associated with melanoma. This mutation leads to constitutive activation of the MAPK pathway, contributing to tumor progression. Studies have identified a BRAF mutation-associated gene expression signature in MM466, which includes upregulated genes such as TBX3 and downregulated genes like TR@A. Additionally, MM466 has been used in genome-wide analyses to identify loss of heterozygosity (LOH) and copy number changes, revealing frequent LOH on chromosome arms 9p, 10p, 10q, 9q, 6q, 11q, and 17p. The cell line has also been part of studies examining the role of BRAF mutations in melanoma development and therapeutic targeting.

Research Applications

BRAF mutation analysisGene expression profilingLoss of heterozygosity (LOH) analysisCopy number variation (CNV) analysis

Key Characteristics

BRAF V599E mutationConstitutive MAPK pathway activationGenome-wide LOH and CNV alterations
Generated on 6/21/2025

Basic Information

Database IDCVCL_4449
SpeciesHomo sapiens (Human)
Tissue SourceLymph node[UBERON:UBERON_0000029]

Donor Information

Age CategoryUnknown
SexFemale

Disease Information

DiseaseMelanoma
LineageSkin
SubtypeMelanoma
OncoTree CodeMEL

DepMap Information

Source TypeCellBank Australia
Source IDACH-001971_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleBRAFp.Val600Glu (c.1799T>A)Unspecified-PubMed=26214590
Gene deletionCDKN2A-HomozygousPossiblePubMed=26870271

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,11
D13S317
11
D16S539
12,13
D18S51
12,19
D19S433
14,15
D21S11
28,29
D2S1338
17
D3S1358
15
D5S818
11,12
D7S820
9,10
D8S1179
10,12
FGA
22,26
TH01
9,9.3
TPOX
9
vWA
15,17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Confirmation of a BRAF mutation-associated gene expression signature in melanoma.

Johansson P., Pavey S., Hayward N.K.

Pigment Cell Res. 20:216-221(2007).

Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.

Stark M.S., Hayward N.K.

Cancer Res. 67:2632-2642(2007).

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

Meltzer P.S., Ringner M., Hayward N.K.

Oncogene 23:4060-4067(2004).

CDKN2A/p16 is inactivated in most melanoma cell lines.";

Gabrielli B.G., Parsons P.G., Hayward N.K.

Cancer Res. 57:4868-4875(1997).